How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €447.00 | €475.64 |
| Alphabet Inc. A | €173.10 | €189.01 |
| Amazon.com Inc. | €191.06 | €223.82 |
| Security | Price | Target price |
|---|---|---|
| Tesla Inc | €281.95 | €302.74 |
| Albemarle Corp | €65.71 | €99.39 |
| T.Rowe Price Group Inc. | €90.33 | €81.50 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Viasat Inc. | William Blair | 41.23% |
| B Solarmax Technology Inc. | Warner | 27.01% |
| B Assembly Biosciences Inc. | blaugold | 25.63% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Solarmax Technology Inc. | Bankster | -52.38% |
| S Solarmax Technology Inc. | Warner | -47.70% |
| S Figma Inc. | daimler1 | -32.74% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
This new day by Dom Ruinart
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Viking Therapeutics Inc
WKN: A12GD6 / Name: Viking / Stock / Biotechnology & Medical Research / Small Cap /
Pros
Cons
SSR Mining Inc.
WKN: A2DVLE / Symbol: SSRI / Name: SSR Mining / Stock / Metals & Mining / Mid Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Albemarle Corp | €65.71 | 9.280% |
| NortonLifeLock Inc. | €26.60 | 9.020% |
| Gilead Sciences Inc | €102.64 | 8.410% |
| Helmerich & Payne Inc | €14.66 | 7.050% |
| Monster Beverage Corp. | €55.55 | 6.460% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Under Armour Inc. A | €4.67 | -17.960% |
| Warner Bros. Discovery Inc. | €9.40 | -7.590% |
| Microchip Tech. | €53.55 | -5.460% |
| Akamai Tech. | €60.78 | -5.360% |
| Assurant Inc. | €174.00 | -4.420% |
Courses
Get started on the stock market in these easy steps
Things you will learn:
- What is a stock
- What is a fund
- What is an ETF
- How to open a depot
- How to manage a depot that will regularly beat managed funds
- Why you mostly need patience to succeed on the stock market
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Predictions
Top News
Dutch Bros Just Flipped the Script With a Massive Earnings Beat
Who needs coffee? Dutch Bros Inc. (NYSE: BROS) is giving investors a rush as BROS stock is up over 20% in mid-day trading after the company delivered a strong earnings report after the market
Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?
For weight loss drug leaders, the last two weeks have been nothing short of disastrous for shares.
Industry pioneer Novo Nordisk A/S (NYSE: NVO) saw its stock drop nearly 22% on July 29 after
Tesla Is Balanced on a Knife Edge: Time to Tread Carefully
Shares of auto-giant Tesla Inc (NASDAQ: TSLA) popped more than 3.5% on Aug. 6, snapping a mini losing streak and reigniting hopes that a bullish breakout is just around the corner. The stock has
Why Axon's 16% Surge Signals a New Era in Public Safety Tech
In a decisive session that caught investors' attention, shares of Axon Enterprise (NASDAQ: AXON) climbed by 16.41% on August 5, 2025. The stock closed at a new 52-week high of $867.12 on a wave of
DraftKings Posts Record Quarter, Eyes Profitability
DraftKings Inc. (NASDAQ: DKNG) reported record revenue and earnings in its second-quarter 2025 earnings report. This was expected, as DKNG stock was up approximately 11% in the month before
Here's What Key Metrics Tell Us About Sweetgreen (SG) Q2 Earnings
For the quarter ended June 2025, Sweetgreen, Inc. (SG) reported revenue of $185.58 million, up 0.5% over the same period last year. EPS came in at -$0.20, compared to -$0.13 in the year-ago quarter.
Compared to Estimates, Monster Beverage (MNST) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2025, Monster Beverage (MNST) reported revenue of $2.11 billion, up 11.1% over the same period last year. EPS came in at $0.52, compared to $0.41 in the year-ago quarter.
Carlyle Touches 52-Week High: How to Approach the Stock Now?
The Carlyle Group Inc. CG shares touched a new 52-week high of $64.09 during yesterday's trading session. The stock closed the session a little lower at $61.57.
CG’s shares have gained 57.5% in the
Monster Beverage Q2 Earnings Beat, Higher Sales Across Most Segments Aid
Monster Beverage Corporation (MNST) delivered solid second-quarter 2025 earnings, wherein the bottom line beat the Zacks Consensus Estimate and increased year over year.
The company has seen growth
Compared to Estimates, Datadog (DDOG) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2025, Datadog (DDOG) reported revenue of $826.76 million, up 28.1% over the same period last year. EPS came in at $0.46, compared to $0.43 in the year-ago quarter.
The
Pediatrix Medical's Q2 Earnings Beat on Strong Patient Volumes
Shares of Pediatrix Medical Group, Inc. MD have gained 12.1% since it reported second-quarter 2025 results on Aug. 5. The quarterly results were aided by higher patient volumes, improved patient
News
Can ConocoPhillips' Strategic Divestments Support Long-Term Growth?
ConocoPhillips COP is a leading player in the energy sector, primarily involved in exploration and production activities, with a strong global presence. The company highlights that it has a durable
Citizens & Northern (CZNC) Misses Q2 Earnings Estimates
Citizens & Northern (CZNC) came out with quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.4 per share a year ago. These
Crocs Q2 Earnings Surpass Estimates, Revenues Increase 3.4%
Crocs, Inc. CROX has reported strong second-quarter 2025 results, wherein the top line was in line with the Zacks Consensus Estimate, while the bottom line surpassed the estimates. Meanwhile, both
Vistra Q2 Earnings Beat Estimates, Revenues Miss, Both Up Y/Y
Vistra Corp. VST reported second-quarter 2025 earnings of $1.01 per share, which beat the Zacks Consensus Estimate of 98 cents by 3.1%. In the year-ago quarter, the company reported earnings of 90
Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2025, Sotera Health Company (SHC) reported revenue of $294.34 million, up 6.4% over the same period last year. EPS came in at $0.20, compared to $0.19 in the year-ago
Restaurant Brands Q2 Earnings Miss Estimates, Rise Y/Y, Stock Down
Restaurant Brands International, Inc. QSR reported mixed second-quarter 2025 results, with earnings missing the Zacks Consensus Estimate but increasing on a year-over-year basis. Meanwhile, net
IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi
Iovance Biotherapeutics IOVA incurred a second-quarter 2025 loss of 33 cents per share, wider than the Zacks Consensus Estimate of a loss of 29 cents. In the year-ago quarter, the company reported a
Here is Why Growth Investors Should Buy SunOpta (STKL) Now
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth
Is Idexx (IDXX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobieren
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.